Download Files:
Fenoldopam
SKU
HY-B0735-Get quote
Category Reference compound
Tags Cardiovascular Disease, Dopamine Receptor, GPCR/G Protein;Neuronal Signaling
Web ID
– HY-B0735
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C16H16ClNO3
Citations
– Biochem Biophys Res Commun. 18 December 2021.|Biomed Pharmacother. 2021, 111500.|SLAS Discov. 2020 Sep;25(8):895-905.|Cell. 2021 Feb 18;184(4):943-956.e18.
References
– [1]Grenader, A. and D.P. Healy, Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther, 1991. 258(1): p. 193-8.|[2]Nichols, A.J., R.R. Ruffolo, Jr., and D.P. Brooks, The pharmacology of fenoldopam. Am J Hypertens, 1990. 3(6 Pt 2): p. 116S-119S.
CAS Number
– 67227-56-9
Molecular Weight
– 305.76
SMILES
– OC1=C(O)C=C2C(C3=CC=C(O)C=C3)CNCCC2=C1Cl
Clinical Information
– Launched
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Dopamine Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.